CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
甘精胰岛素治疗糖尿病与恶性肿瘤发生风险的荟萃分析
Authors
温慧萍
薛鸿林
陈沭
黄文辉
Publication date
15 August 2019
Publisher
Abstract
目的:系统评价糖尿病患者用甘精胰岛素治疗与恶性肿瘤发生风险的相关性。方法:检索PubMed数据库、中国期刊全文数据库(CNKI)、万方数据库(Wanfang Data)、中文科技期刊全文数据库(VIP)建库至2018年2月的相关文献资料。按Cochrane系统评价方法进行文献筛选,将纳入的文献进行数据提取和质量分析后,采用RevMan 5.3软件进行荟萃(meta)分析。结果:共纳入16篇文献。分析结果显示,甘精胰岛素组发生恶性肿瘤的风险与安慰剂/其他降糖药组相似,差异无统计学意义[RR=0.98,95%CI(0.83,1.16),P=0.80]。进一步研究发现,甘精胰岛素组发生乳腺癌、结直肠癌和前列腺癌的风险均与安慰剂/其他降糖药组相似,差异无统计学意义(P>0.05)。结论:甘精胰岛素未增加糖尿病患者乳腺癌、结直肠癌和前列腺癌等恶性肿瘤的发生风险
Similar works
Full text
Open in the Core reader
Download PDF
Available Versions
Xiamen University Institutional Repository
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:dspace.xmu.edu.cn:2288/174...
Last time updated on 20/11/2020